Molecular Diagnostics

|2 min read

AI-Generated Fake References Increasing Across Biomedical Literature, Study Finds

Study finds AI-generated fake citations are becoming increasingly common in biomedical research papers, raising new integrity concerns
|2 min read

Paper-Based Device Detects Cancer Biomarker miRNA-21 via Smartphone Readout

Paper-based nanozyme device enables rapid detection of cancer biomarker miRNA-21 for potential point-of-care use
|4 min read

Infectious Disease Surveillance and Testing: What Clinical Labs Should Expect During the FIFA World Cup

Large-scale global events can heighten infectious disease risks, making laboratory preparedness critical for surveillance and testing, particularly for measles and other highly transmissible diseases
|3 min read

Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice

A regulatory roadmap for AI diagnostic tool development
Sponsored by
Updated |3 min read

How Ultra-Rapid Molecular Diagnostics Are Reshaping the Clinical Laboratory

Ultra-rapid, CLIA-waived molecular testing is reshaping clinical laboratory operations while expanding near-patient diagnostic care
|2 min read

CAP Warns CMS Against Broad Lab Fraud Crackdown

Pathologists say aggressive anti-fraud proposals could increase administrative burdens and restrict access to legitimate molecular testing
|2 min read

Population Screening Identifies Early-Stage Type 1 Diabetes in Children Before Clinical Onset

A new study has found that islet autoantibody testing can identify most children who later develop clinical type 1 diabetes, supporting broader screening efforts
Updated |4 min read

Hantavirus: Diagnosis, Surveillance, and 2026 Outbreak Updates

The recent hantavirus outbreak is highlighting the importance of robust laboratory and surveillance systems
|2 min read

Study Finds HPV Self-Collection Program Boosts Cervical Cancer Screening Rates

Large US rollout increased screening rates, reduced pelvic exams, and improved follow-up care for HPV-positive patients
|2 min read

New Study Could Improve Testing and Treatment for Rare Brain, Spinal Cord, and Eye Cancers

A newly identified biomarker could enable earlier, less invasive diagnosis and improved disease monitoring of some rare and aggressive cancers
|2 min read

New Blood Test Detects Testicular Cancers Missed by Standard Markers

Mayo Clinic researchers have developed two new blood tests that use immune system signals to improve detection and classification of testicular germ cell tumors
|3 min read

What Cell-Free DNA Means for Clinical Laboratories

CAP experts share insights on the clinical utility and evolving role of cfDNA in the clinical laboratory
Page 2 of 107